Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

Abstract

Standard adjuvant chemotherapy is superior to capecitabine in patients with early-stage breast cancer who are 65 years of age or older. (ClinicalTrials.gov number, NCT00024102.)